Europe Urinalysis Market

Market Introduction

Europe consists of five major countries namely Germany, France, UK, Italy, and Spain. The market is also evaluated for the rest of countries in Europe. The market is driven by the factors such as increasing prevalence of hospitals acquired urinary tract infection (UTI), innovative technology and products, increasing adoption of point-of-care urinalysis and growing number of initiatives for launch of highly automated instruments for better diagnosis advancement, in this region.

The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to the lockdown restrictions announced by many European countries that caused disruptions in manufacturing and supply chain operations. Additionally, scheduled appointments and health checkups have been delayed in many clinics. Patients with the UTI suffered the inadequate availability of medical staff providing therapeutic services to treat their conditions. With the number of rising cases, the healthcare workers had to switch between their roles to meet the demand for healthcare staff to manage COVID-19. Hence, it caused a significant decrease in elective procedures due to a lack of healthcare resources. According to National Kidney Foundation, patients hospitalized with COVID-19 are at considerable risk of developing acute kidney injury (AKI), resulting in severe illnesses and death. The COVID-19 patients with blood or protein in their urine need to be continuously monitored as they are at a high risk of developing chronic kidney disease. However, with the implementation of proper precautionary measures and modification of protocols to reduce the chances of exposure to SARS-CoV-2 during patient visits, the hospitals have begun to continue their operations, and a resurgence in testing numbers evident due to relaxations in restrictions imposed on people’s movement.    

Market Overview and Dynamics

The urinalysis market in Europe is expected to grow from US$ 1,161.86 million in 2021 to US$ 1,655.73 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. A rise in the elderly population, increased prevalence of urinary tract infections, and kidney disorders are the major factors driving the urinalysis market's growth. As urine can be used to detect several diseases and diagnose conditions like urinary tract infections, kidney disorders, and diabetes, it is used for easy analysis of diseases. Also, the growing number of hospitals using new technologically advanced facilities in the region is likely to fuel the market's growth during the forecast period. The European Confederation of Laboratory Medicine (ECLM) has also provided stringent guidelines for Urinalysis. The European Urinalysis Guidelines are given under the auspices of the European Confederation of Laboratory Medicine, and these guidelines provide control on every aspect of urinalysis, including collection, preservation, and transport of urine specimens. Many countries are increasing their research and development to introduce innovative products. Therefore, it is expected that the increasing government initiatives and rising cases of UTI are likely to increase the urinalysis market growth during the forecast period.    

Key Market Segments

Europe urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the Europe urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The Europe urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the Europe urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The Europe urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the Europe urinalysis market is segmented into France, Germany, Italy, Spain, the UK, and rest of Europe. Germany held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the urinalysis market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.         

Reasons to buy report

• To understand the Europe urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe urinalysis market.
• Efficiently plan M&A and partnership deals in Europe urinalysis market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe urinalysis market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe

Europe Urinalysis Market -

By Product

• Consumables
• Instruments

Europe Urinalysis Market - By

Test Type

• Pregnancy and Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Europe Urinalysis Market - By Application

• Disease Screening
• Pregnancy and Fertility

Europe Urinalysis Market - By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories and Institutes

Europe Urinalysis Market - By Country

• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe

Europe Urinalysis Market - Company Profiles

• Abbott    
• ACON Laboratories, Inc.             
• ARKRAY, Inc.     
• Beckman Coulter, Inc.     
• Bio-Rad Laboratories Inc.            
• Cardinal Health Inc         
• F. Hoffmann-La Roche Ltd.          
• Quidel Corporation          
• Siemens Healthineers AG           
• Sysmex Corporation

Europe Urinalysis Strategic Insights

Strategic insights for the Europe Urinalysis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Urinalysis Report Scope

Europe Urinalysis Regional Insights

The geographic scope of the Europe Urinalysis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.